These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 7103350)

  • 1. [Glycosylated hemoglobin and clinical estimate of the degree of control of diabetes. Relations to glycemia, cholesterolemia, triglyceridemia, duration of diabetes and retinopathy. Study of 85 children and adolescents].
    Dorchy H; Despontin M; Haumont D; Toussaint D; de Vroede M; Loeb H
    Ann Pediatr (Paris); 1982 May; 29(5):319-26. PubMed ID: 7103350
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycosylated hemoglobin and clinical evaluation of the degree of diabetes control. Relation to blood sugar, blood cholesterol, blood triglycerides, and the duration of diabetes and retinopathy. Study of 85 diabetic children and adolescents].
    Dorchy H; Despontin M; Haumont D; Toussaint D; De Vroede M; Loeb H
    Sem Hop; 1982 Dec; 58(47):2773-80. PubMed ID: 6301021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term blood glucose control and diabetic retinopathy.
    Finotti P; Piccoli A
    Lancet; 1990 Jan; 335(8681):107-8. PubMed ID: 1967384
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycosylated hemoglobin (Hb AI) as an indicator of therapy effects in different clinical types of diabetes.
    Czech A; Tatoń J
    J Chronic Dis; 1983; 36(11):803-10. PubMed ID: 6643647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylated hemoglobin in a population-based study of diabetes.
    Klein R; Klein BE; Moss SE; Shrago ES; Spennetta TL
    Am J Epidemiol; 1987 Sep; 126(3):415-28. PubMed ID: 3303917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus.
    Warram JH; Manson JE; Krolewski AS
    N Engl J Med; 1995 May; 332(19):1305-6. PubMed ID: 7708084
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum markers of oxidative stress and severity of diabetic retinopathy.
    Hartnett ME; Stratton RD; Browne RW; Rosner BA; Lanham RJ; Armstrong D
    Diabetes Care; 2000 Feb; 23(2):234-40. PubMed ID: 10868837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good blood glucose control characterizes patients without retinopathy after long diabetes duration.
    Kullberg CE; Arnqvist HJ
    Diabet Med; 1995 Apr; 12(4):314-20. PubMed ID: 7600746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type 1 diabetes.
    Kordonouri O; Wladimirowa A; Danne T
    Diabetes Care; 2000 Jul; 23(7):1025-6. PubMed ID: 10895863
    [No Abstract]   [Full Text] [Related]  

  • 10. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy.
    Klein BE; Knudtson MD; Tsai MY; Klein R
    Arch Ophthalmol; 2009 Sep; 127(9):1175-82. PubMed ID: 19752427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual function in young IDDM patients over 8 years of age. A 4-year longitudinal study.
    North RV; Farrell U; Banford D; Jones C; Gregory JW; Butler G; Owens DR
    Diabetes Care; 1997 Nov; 20(11):1724-30. PubMed ID: 9353616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Normal glycemia and high glycosylated hemoglobin in a diabetic child].
    Chevallier B; Alexandre JA; Renaud C; Teinturier A
    Arch Fr Pediatr; 1991; 48(6):443. PubMed ID: 1929739
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid profile in diabetic patients, according to changes in glucose control: a 2-year study].
    Sancho Serrano MA; Jiménez Aznarez A; Sanz París A
    An Med Interna; 1993 Oct; 10(10):479-83. PubMed ID: 8136424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in glycemia in a four-year interval in younger-onset insulin-dependent diabetes.
    Klein R; Moss SE; Klein BE
    Ann Epidemiol; 1992 May; 2(3):283-94. PubMed ID: 1342279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised serum apolipoprotein (a) in active diabetic retinopathy.
    Maioli M; Tonolo G; Pacifico A; Ciccarese M; Brizzi P; Kohner EM; Porta M
    Diabetologia; 1993 Jan; 36(1):88-90. PubMed ID: 8436260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.
    Lloyd CE; Klein R; Maser RE; Kuller LH; Becker DJ; Orchard TJ
    J Diabetes Complications; 1995; 9(3):140-8. PubMed ID: 7548977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.
    Klein R; Klein BE; Moss SE; Cruickshanks KJ
    Ophthalmology; 1998 Oct; 105(10):1801-15. PubMed ID: 9787347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic retinopathy in chronic pancreatitis.
    Gullo L; Parenti M; Monti L; Pezzilli R; Barbara L
    Gastroenterology; 1990 Jun; 98(6):1577-81. PubMed ID: 2338195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.